According to findings published in the Canadian Medical Association Journal, the sequencing provided a molecular diagnosis for 40 percent of the infants in the study. The technique can be performed in hospitals without having to send away for results and significantly speed the generation of a treatment plan, according to the authors.
“Enabling the family to understand why their baby is ill can help to assuage the almost universal guilt felt by parents that they did something wrong to cause their baby’s illness,” Sarah Bowdin, MD, co-author of the study, wrote in a commentary accompanying the research. “It can also indicate whether other family members may be at risk of the same disease and provide an accurate recurrence risk for future pregnancies.”
More articles on genomics in healthcare:
Not-so-sensitive data: The case for unprotected health information
UW Medicine signs deal with Chinese genomics firm to advance biomedical tech
9 questions about precision medicine, answered
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
